『Antipyretic analgesic and anti-inflammatory drug 'Dexidifen 400mg' launched』
KyungDong Pharm Co., Ltd. launches the antipyretic analgesic and anti-inflammatory drug ‘Dexidifen 400mg’ on October 1, 2020.
This drug assists in the treatment of infections accompanied by inflammation, pain, and fever.
It is a preferred drug in various departments as it can be prescribed for a very wide range of inflammation treatments.
It has excellent anti-inflammatory and analgesic effects and is particularly strong in reducing fever.
Dexibuprofen, the ingredient of this drug, is formulated by separating only the pharmacologically effective portion from ibuprofen.
It is faster and lasts longer, and the effect is proportional to the dose, so high efficacy can be expected.
In particular, our product ‘Dexidifen Tablet 400mg’ is the only product with the same ingredient content that has undergone a viability test.
‘Dexidifen Tablet 400mg’, which has various advantages, is widely used in internal medicine, otolaryngology, etc.
It is expected to be an item that will lead to increased sales of KyungDong Pharm in various medical departments.
♤ Product Information ♤
|
Product Name |
Dexidifen tablets 400mg |
|
Ingredient content |
Dexibuprofen D.C. 400mg |
|
Indications |
1. Chronic polyarthritis, rheumatoid arthritis 2. Arthropathy 3. Ankylosing spondylitis 4. Painful swelling or inflammation after trauma or surgery 5. Aid in the treatment of infections accompanied by inflammation, pain, and fever |
|
Dosage and usage |
Adults: Orally administer 400 mg of dexibuprofen 2-3 times a day. However, do not exceed 1,200 mg of dexibuprofen per day. |
|
Packaging unit |
30T/bottle, 100T/bottle |
※ Please refer to the product manual for other details such as precautions for use.